STIC registration trial for serous cancer risk
Part of Cancer, Hormones & metabolism, Women’s health & pregnancy clinical trials.
This trial tracks women who had a precancerous cell change in their fallopian tubes (STIC) but no invasive cancer. By enrolling in a registry, you help researchers understand how often this condition leads to future cancer and how to best manage it.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman.
- Both of your fallopian tubes have been removed (with or without ovaries).
- You were diagnosed with a specific precancerous change called STIC in your fallopian tubes, confirmed by a pathologist.
- You did not have any invasive cancer found during that surgery or when the tissue was checked under a microscope.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks for early signs of ovarian cancer in a simple blood test. It may help people with BRCA gene changes catch problems sooner, before or after preventive surgery.
This study follows women who carry BRCA1 or BRCA2 gene variants (or a gene variant of unclear meaning) to learn about their risks over time. It may help improve how genetic information is used to guide future care.
This study compares two risk-reducing surgery plans for people with a BRCA1 genetic change to see which approach helps lower ovarian cancer risk. You may be asked to have the study procedure sooner or later depending on your chosen plan.
This study will collect medical information from people with advanced ovarian, peritoneal, or fallopian tube cancer. The goal is to learn more about these cancers and improve future treatments.
This trial tests if removing the fallopian tubes (fimbriectomy) can lower the risk of ovarian or pelvic cancer in women with certain gene mutations. The goal is to find a less invasive prevention option.
This study looks at the genetic activity in ovarian and fallopian tube tissue from women with and without BRCA mutations. It aims to find early changes that might lead to cancer.
Hear when a new BRCA Mutation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.